Moody National Bank Trust Division’s State Street SPDR S&P Biotech ETF XBI Stock Holding History

Moody National Bank Trust Division’s Portfolio XBI Stock Details XBI Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q2	–	Sell	-890	Closed	-$81K	–	982
2019 Q1	$81K	Hold	890	–	–	﹤0.01%	386
2018 Q4	$64K	Hold	890	–	–	﹤0.01%	385
2018 Q3	$85K	Buy	+890	New	+$86.3K	﹤0.01%	353

Other funds holding XBI

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

BNP Paribas Financial Markets Paris, France $206B AUM 31.61% 1-Year Est. Return

Citigroup New York $303B AUM 53.02% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Barclays London, United Kingdom $416B AUM 33.63% 1-Year Est. Return

Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return

Two Sigma Advisers New York $51.4B AUM 31.07% 1-Year Est. Return

Moody National Bank Trust Division's XBI Position: Q2 2019 in Review

Moody National Bank Trust Division sold out of State Street SPDR S&P Biotech ETF (XBI) in Q2 2019, closing a stake of 890 shares — an estimated $81K sold.

Moody National Bank Trust Division first reported a position in XBI in Q3 2018 and held it in 3 quarters. The position peaked at $85K in Q3 2018. 424 funds tracked by Wall St. Rank hold XBI as of Q2 2019.

Moody National Bank Trust Division reported no remaining State Street SPDR S&P Biotech ETF position as of Q2 2019 after selling out during the quarter.
Moody National Bank Trust Division sold 890 State Street SPDR S&P Biotech ETF shares in Q2 2019, an estimated $81K.
Moody National Bank Trust Division first reported a position in State Street SPDR S&P Biotech ETF in Q3 2018 and held it in 3 quarters.
Moody National Bank Trust Division's State Street SPDR S&P Biotech ETF position peaked at $85K in Q3 2018.
424 funds tracked by Wall St. Rank held State Street SPDR S&P Biotech ETF as of Q2 2019.

Based on Moody National Bank Trust Division's 13F filing for Q2 2019, filed 22 Jul 2019.